Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 16 results when searching "Buprenorphine"

PATHWAY

Opioid dependence : Opioid detoxification

Any patient deemed at risk of opiate overdose (or their representative/carer), including all those on Opiate Substitution Treatment, should be given instruction in overdose prevention, basic life supp...

INFO

NHS Lothian Shared Care Agreements

The NHS Lothian Policy and Procedures for the Shared Care of Medicines is available from the NHS Lothian Medicines Governance Policies page. Template documents relating to local shared care arrangemen...

DOCUMENT

24/11/2021 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 24 November 2021 Page 1 of 24 East Region Formulary Committee Minutes Date: 24 November 2021 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead P...

DOCUMENT

30/11/2022 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 30 November 2022 Page 1 of 21 East Region Formulary Committee Minutes Date: 30 November 2022 Time: 2pm – 4pm Location: MS Teams Present: Alison Casey Senio...

DOCUMENT

27/07/2022 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 25 May 2022 Page 1 of 15 East Region Formulary Committee Minutes Date: 27 July 2022 Time: 2pm – 4pm Location: MS Teams Present: Ruth Cameron Advanced Clini...

DOCUMENT

02/02/2022 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 02 February 2022 Page 1 of 15 East Region Formulary Committee Minutes Date: 02 February 2022 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead P...

FORMULARY DECISION

Buprenorphine + Naloxone : Zubsolv

SMC2123 : Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. The intention of the naloxone component is to deter intravenous misuse. ...

FORMULARY DECISION

Buprenorphine : Transtec

116/04 : Moderate to severe cancer pain and severe pain that does not respond to non-opioid analgesics

FORMULARY DECISION

Buprenorphine + Naloxone : Buprenorphine + naloxone

355/07 : For restricted use within NHS Scotland for substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. Buprenorphine/naloxone is rest...